In Vitro–In Vivo Extrapolation of Metabolism- and Transporter-Mediated Drug–Drug Interactions—Overview of Basic Prediction Methods
- 1 September 2017
- journal article
- review article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 106 (9) , 2209-2213
Abstract
No abstract availableKeywords
Funding Information
- U.S. FDA's Medical Countermeasures initiative
This publication has 35 references indexed in Scilit:
- Review of P‐gp Inhibition Data in Recently Approved New Drug Applications: Utility of the Proposed [I1]/IC50 and [I2]/IC50 Criteria in the P‐gp Decision TreeThe Journal of Clinical Pharmacology, 2013
- PET Imaging–Based Evaluation of Hepatobiliary Transport in Humans with (15R)-11C-TIC-MeJournal of Nuclear Medicine, 2012
- Cytochrome P450 3A4 mRNA Is a More Reliable Marker than CYP3A4 Activity for Detecting Pregnane X Receptor-Activated Induction of Drug-Metabolizing EnzymesDrug Metabolism and Disposition, 2010
- Evaluation of models for predicting drug–drug interactions due to inductionExpert Opinion on Drug Metabolism & Toxicology, 2010
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- Comparison of Different Algorithms for Predicting Clinical Drug-Drug Interactions, Based on the Use of CYP3A4 in Vitro Data: Predictions of Compounds as Precipitants of InteractionDrug Metabolism and Disposition, 2009
- Method for predicting the risk of drug–drug interactions involving inhibition of intestinal CYP3A4 and P-glycoproteinXenobiotica, 2009
- A regulatory viewpoint on transporter-based drug interactionsXenobiotica, 2008
- When good drugs go badNature, 2007
- Predicting in vivo drug interactions from in vitro drug discovery dataNature Reviews Drug Discovery, 2005